Cognitive impairment is a common and disabling feature of MS, affecting 40-70% of patients. Altering the behaviour and quality of life of MS patients, it can lead to social and personal difficulties, sometimes despite minimal concurrent physical disability. Information processing speed and episodic memory are the cognitive functions most frequently affected in MS, but additional difficulties in executive function, verbal fluency, and visuospatial abilities have been reported. MRI has proven to represent a powerful tool in investigating the neuroanatomy of cognitive impairment in MS patients, but a precise characterisation of cognitive phenotypes is still lacking.
In a study presented by Dr Ermelinda De Meo (Vita-Salute San Raffaele University, Italy), 1,212 clinically stable MS patients were compared with 196 healthy controls on a clinical, neuropsychological, and neuroanatomical level [1]. Based on the results, 5 cognitive phenotypes of MS were identified:
- preserved cognition in 19% of patients;
- mild verbal memory/semantic fluency in 30%;
- mild multi-domain involvement in 19%;
- severe attention/executive involvement in 14%; and
- severe multi-domain involvement in 18%.
Patients with a preserved cognition and/or mild-verbal memory/semantic fluency were on average younger and had shorter disease duration compared with individuals manifesting other phenotypes. Physical disability was lowest in patients with a preserved cognition and highest in patients with a severe multi-domain involvement. Severe cognitive phenotypes prevailed in progressive patients.
At MRI evaluation, reduced hippocampal volume was associated with mild verbal memory/semantic fluency, reduced cortical grey matter volume was associated with mild multi-domain involvement, higher T2-hyperintense lesion volume was associated with severe attention/executive involvement, and extensive brain damage was associated with severe multi-domain involvement.
- De Meo E, et al. Identifying distinct cognitive phenotypes in multiple sclerosis. ECF 28th Annual Meeting. Abstract 50.
Posted on
Previous Article
« First long-term efficacy data of a BTK inhibitor Next Article
No association between Ig levels and infection in ofatumumab-treated patients with relapsing MS »
« First long-term efficacy data of a BTK inhibitor Next Article
No association between Ig levels and infection in ofatumumab-treated patients with relapsing MS »
Table of Contents: ECF 2020
Featured articles
ECF Round-Up Articles
No association between Ig levels and infection in ofatumumab-treated patients with relapsing MS
Defining phenotypes of MS-related cognitive impairment
First long-term efficacy data of a BTK inhibitor
Novel disease-specific scale confirms huge impact of fatigue
Progressive aerobic exercise improves fatigue
Reliable and convenient method to assess cognitive function in MS patients
Tackling unmet MS-related cognitive challenges
Real-world efficacy of ocrelizumab in MS patients
Similar demographics, clinical characteristics, and treatment patterns in German claims study
Decreased EDSS after plasma exchange in NMOSD
No support for IVIG as treatment of acute attacks in NMOSD
Related Articles
December 16, 2020
No increased risk with IFN-β use during pregnancy
December 16, 2020
Decreased EDSS after plasma exchange in NMOSD
December 16, 2020
Tackling unmet MS-related cognitive challenges
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com